Dihydroberberine (GlucoVantage) vs Nattokinase

Mechanism

Active metabolite of berberine with 5x greater absorption. AMPK activator that improves insulin sensitivity, reduces hepatic glucose production, and modulates gut microbiome. More bioavailable form allows lower dosing with fewer GI side effects.

Contraindications

• Same as berberine — hypoglycemia risk with diabetic medications

Mechanism

Nattokinase is a fibrinolytic serine protease extracted from natto (fermented soybeans). It directly degrades fibrin (the structural protein of blood clots) through four mechanisms: direct fibrinolysis, enhancement of endogenous tPA (tissue plasminogen activator) production, conversion of prourokinase to urokinase, and degradation of PAI-1 (plasminogen activator inhibitor-1). It also reduces blood viscosity and may inhibit ACE (angiotensin-converting enzyme), providing mild antihypertensive effects.

Standard Dosing

2000-4000 FU (fibrinolytic units) daily, equivalent to 100-200mg

Timing

On empty stomach, between meals or before bed. Morning and evening split dosing for 24-hour fibrinolytic coverage.

Cycle Duration

ongoing

Side Effects

• Easy bruising
• Nosebleeds
• GI upset
• Rare: serious bleeding events

Contraindications

• Active bleeding or bleeding disorders
• Scheduled surgery (discontinue 2+ weeks prior)
• Concurrent anticoagulant/antiplatelet therapy
• Hemorrhagic stroke history
• Soy allergy
• Active bleeding
• Bleeding disorders
• Pre-surgery (stop 2 weeks prior)
• Concurrent anticoagulation therapy without physician supervision

Best Stacking Partners